Rate this post

MedVi vs MyStart: Compare GLP-1 Programs & Pricing

Side-by-side MedVi and MyStart: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.

MedVi and MyStart are two established telehealth providers offering GLP-1–based weight‑management programs. This article compares MedVi vs MyStart to help you identify which best fits your goals, budget, and comfort with virtual care.

Visit MedVi
Explore MyStart

MedVi vs MyStart: Quick Overview

Provider	Semaglutide	Tirzepatide	Promo	Membership
MedVi	$179.00	$279.00	$120 off first month (Code: )	— No
MyStart	$179.00	$299.00	(Code: EXPLORE2026)	—

MedVi vs MyStart: Medical Process & Accessibility

Both platforms operate fully online, allowing you to complete intake forms, upload medical history, and schedule a video or phone consult from the comfort of home. MedVi emphasizes a rapid intake workflow—most users receive prescription approval within 24‑48 hours after the clinician review. MyStart incorporates a structured onboarding sequence that includes a baseline assessment, a personalized dosing plan, and scheduled follow‑up visits to fine‑tune the regimen. All prescriptions are routed to FDA‑registered compounding pharmacies that follow USP ^® standards, ensuring product quality and safety.

Start with MedVi

MedVi vs MyStart: Pricing Comparison

MedVi starts semaglutide at $179.00 and tirzepatide at $279.00. MyStart offers the same semaglutide price of $179.00 but lists tirzepatide at $299.00. The lower tirzepatide price is highlighted in bold for quick reference. Both companies provide a first‑month discount: MedVi offers $120 off (no promo code required), while MyStart applies the code EXPLORE2026 at checkout.

Neither provider lists an ongoing membership fee, but each may charge a one‑time onboarding fee for lab work or additional clinician time. Be sure to review the fine print on each site before committing, as ancillary costs can affect the total monthly outlay.

Compare MyStart Pricing

MedVi vs MyStart: Clinical Oversight & Support

Clinical oversight is a cornerstone of telehealth compliance. Both MedVi and MyStart employ board‑certified endocrinologists, obesity specialists, or nurse practitioners who are authorized to prescribe GLP‑1 agents under FDA‑approved indications. MedVi’s model leans toward a streamlined prescription process—ideal for patients who have already been evaluated by a primary‑care physician and simply need a GLP‑1 prescription. MyStart, on the other hand, builds in regular virtual check‑ins (typically every 2–4 weeks) to monitor weight loss, side‑effects, and dose adjustments, mirroring the care cadence of an in‑person weight‑management clinic.

Book a Consultation with MedVi

MedVi vs MyStart: Medication Quality & Safety

Both companies dispense compounded GLP‑1 medications that are legally prescribed in the United States when a licensed clinician signs off. The compounds are manufactured in FDA‑registered facilities and must meet strict sterility and potency standards. While they are not identical to branded products such as Wegovy® or Mounjaro®, they contain the same active ingredients (semaglutide or tirzepatide) in equivalent therapeutic doses. Patients should be aware that, as with any medication, GLP‑1 agents carry FDA‑listed warnings—including risk of pancreatitis, gallbladder disease, and thyroid C‑cell tumors—so ongoing clinician monitoring is required.

MedVi vs MyStart: Customer Experience

Customer reviews frequently cite MedVi’s speed and affordability as top strengths. Users appreciate the quick turnaround from intake to medication delivery (often within 5‑7 business days). MyStart receives praise for its thorough education materials, responsive care team, and proactive dose titration, which can lead to smoother side‑effect management. Both platforms report high satisfaction rates for shipping reliability, packaging discretion, and the ability to manage the entire process from a smartphone.

Explore MyStart Reviews

MedVi vs MyStart: Insurance & Payment Options

At present, most telehealth GLP‑1 programs—including MedVi and MyStart—operate on a cash‑pay model because many private insurers have not yet covered compounded versions of these drugs. Both providers accept major credit cards, debit cards, and ACH transfers. Some users report success using flexible spending accounts (FSAs) or health savings accounts (HSAs) to offset out‑of‑pocket costs, but you should verify eligibility with your plan administrator.

Join MedVi
Get Started with MyStart

MedVi vs MyStart: Final Verdict

If you prioritize low‑cost entry and rapid prescription fulfillment, MedVi is the clear choice. Its straightforward pricing, $120 first‑month discount, and lack of mandatory membership make it attractive for budget‑conscious patients. If you value a more hands‑on clinical experience, regular follow‑up appointments, and a structured education program, MyStart may better align with your expectations—even though its tirzepatide price is slightly higher.

Both services are FDA‑compliant, staffed by licensed clinicians, and partner with accredited compounding pharmacies, ensuring you receive a safe, effective GLP‑1 therapy. Your decision should ultimately rest on the level of support you desire, your comfort with telehealth workflows, and the total cost after discounts.

Start Your MedVi Journey
Begin with MyStart

Disclaimer

This article is for informational purposes only and does not constitute medical advice. ExploreProviders may receive affiliate commissions at no cost to you. Always consult a licensed clinician before beginning any medical treatment.

⭐ Editor’s Choice